pipette
ESEspañol

FDA’s Testosterone Label Changes

Shalender Bhasin, Richard Joseph Auchus, Alvin M. Matsumoto

Peer-reviewed journalReal-world useEasy to read

In the authors' words

This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.

Main result
This Perspective discusses US Food and Drug Administration (FDA) updates to testosterone product labeling and their implications for prescribing practice.

Appeared: Saturday, October 17. JAMA. Peer-reviewed journal.

DOI: 10.1001/jama.2026.18140